Search Results

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
new paper alert
Jun 29, 2024, 12:49 | Insight
New Paper Alert! Proteogenomic Analysis Identified New Cancer Drug Targets Across 10 Cancer Types
Proteogenomic Analysis Identified New Cancer Drug Targets Across 10 Cancer Types         …
Jun 28, 2024, 11:08 | Insight
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results Authors: E. Felip, B.C.…
Jun 26, 2024, 08:00 | Insight
New Paper Alert! Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial
Perioperative Modified FOLFIRINOX Improves Survival in Resectable Pancreatic Cancer: Results from a Phase 2 Trial…
Jun 25, 2024, 14:38 | Insight
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results       …
Jun 24, 2024, 04:49 | Insight
New Paper Alert!- PARP Inhibitor Rucaparib Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer with HRR Mutations
PARP Inhibitor Rucaparib Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer with HRR Mutations Authors: Mark…
Jun 22, 2024, 14:12 | Insight
New Paper Alert! Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures
Novel Tool Predicts Chemotherapy Response in Pancreatic Cancer Using AI-assisted Transcriptomic Signatures Authors: Nicolas Fraunhoffer,…
Jun 21, 2024, 07:54 | Insight
New Paper Alert! New Study Reveals Lower than Expected Gastric Cancer Risk for CDH1 Mutation Carriers
New Study Reveals Lower than Expected Gastric Cancer Risk for CDH1 Mutation Carriers Authors: Carrie…
Jun 21, 2024, 02:08 | Insight
New Paper Alert! AtezoTRIBE Study
AtezoTRIBE Study: Adding Atezolizumab to FOLFOXIRI/Bevacizumab Improves Survival in Metastatic Colorectal Cancer, Especially in Biomarker-Selected…
Jun 14, 2024, 01:23 | Insight
New Paper Alert! Promising Results for MSS Colorectal Cancer Treated with Balstilimab and Botensilimab
Promising Results for MSS Colorectal Cancer Treated with Balstilimab and Botensilimab Authors: Andrea J. Bullock,…
May 4, 2024, 12:13 | Insight
New Paper Alert! Understanding MSI and MMR in Urothelial Carcinoma: Systematic Review and Meta-analysis
Understanding MSI & MMR in Urothelial Carcinoma: Systematic Review and Meta-analysis Authors: Elias B A…
All: 49 Posts: 1 - 10